A patient with cirrhosis is diagnosed with splenomegaly during a routine examination. Which hematologic abnormalities should the nurse anticipate assessing due to the pathophysiology of splenomegaly in this condition?

Cirrhosis-related splenomegaly results from portal hypertension, leading to congestive splenic enlargement, hypersplenism, and increased sequestration of blood elements causing cytopenias including anemia, thrombocytopenia, and leukopenia due to accelerated splenic pooling and destruction of formed blood cells. Rationale: A. Increased hemoglobin and hematocrit are not expected in splenomegaly associated with cirrhosis. Fluid retention typically causes dilutional effects rather than concentration. Hemodilution and hypersplenism reduce circulating blood components. This option contradicts the expected cytopenic profile seen in portal hypertension related splenic enlargement pathology. B. Isolated thrombocytopenia from immune destruction is characteristic of immune thrombocytopenic purpura, not cirrhosis-related splenomegaly. In hypersplenism, multiple cell lines are affected. Splenic sequestration causes pancytopenia rather than isolated platelet loss. This option incorrectly excludes anemia and leukopenia commonly seen in advanced liver disease. C. Anemia, thrombocytopenia, and leukopenia occur due to hypersplenism, where enlarged spleen sequesters and destroys red cells, platelets, and leukocytes. Portal hypertension drives splenic congestion leading to cytopenias. This reflects classic triad seen in cirrhosis with splenomegaly and impaired hematologic circulation function. D. Polycythemia, leukocytosis, and thrombocytosis are not associated with cirrhosis or splenomegaly. Bone marrow suppression and splenic sequestration reduce cell counts rather than increase them. Myeloproliferation is absent in this condition. This option contradicts pathophysiologic mechanism of portal hypertension and hypersplenism state.